Biotech News

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Opko (OPKO)Opko2026-06-25 13:46 ESTCompany update

OPKO (OPKO) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is opko.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

OPKOOpko2026-06-25 13:46 EST

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

OPKOOpko2026-06-25 13:46 EST

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

OPKOOpko2026-06-25 13:46 EST

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

OPKOOpko2026-06-25 13:46 EST

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

OPKOOpko2026-06-25 13:46 EST

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

OPKOOpko2026-06-25 13:46 EST

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

NRSNNeuroSense Therapeutics2026-06-25 13:46 EST

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

JAGXJaguar Health2026-06-25 13:46 EST

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend

MKTMaia Biotechnology2026-06-25 13:46 EST

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

CADLCandel Therapeutics2026-06-25 13:46 EST

Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

View all latest news

Opko

OPKO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

OPKOOpko2026-06-26 11:26 EST

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

OPKOOpko2026-06-26 11:26 EST

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

OPKOOpko2026-06-26 11:26 EST

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

OPKOOpko2026-06-26 11:26 EST

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

OPKOOpko2026-06-26 11:26 EST

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States